)
)
Cinclus Pharma Investor Relations Material
Latest events
Q4 2024
Cinclus Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cinclus Pharma Holding
Access all reports
Cinclus Pharma Holding AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden. The company specializes in the development of treatments for acid-related diseases. Its primary focus is on a drug candidate called linaprazan glurate, which is being developed for the treatment of gastroesophageal reflux disease (GERD) and Helicobacter pylori infections. Linaprazan glurate is designed as a Potassium-Competitive Acid Blocker (P-CAB), offering a potentially more effective alternative to traditional Proton Pump Inhibitors (PPIs) used in treating acid-related conditions. Cinclus Pharma Holding AB is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
CINPHA
Country
🇸🇪 Sweden